QuickView for u0126 (compound)

1. Monocyte-derived dendritic cells treated with MEK inhibitor U0126 or p38/MAPK inhibitor SB203580
2. Prostate cancer DU145 cells expressing ETS1 shRNA or undergoing U0126 treatment
3. NIH-3T3 mouse embryonic fibroblasts expressing RasV12 treated with interferon-alpha or U0126
4. Mammary gland cancer after SHP2 knockout or SHP2 signaling inhibition
5. Fibroblasts treated with U0126 and insulin

1. An Addition of U0126 Protecting Heart Grafts From Prolonged Cold Ischemia-Reperfusion Injury in Hear…
2. mTOR inhibitor temsirolimus and MEK1/2 inhibitor U0126 promote chromosomal instability and cell type…
3. Single-cell heterogeneity in suppression of PC12 differentiation by direct microinjection of a diffe…
4. U0126 protects cells against oxidative stress independent of its function as a MEK inhibitor.
5. U0126 attenuates cerebral vasoconstriction and improves long-term neurologic outcome after stroke in…

There were no clinical trials for u0126